ArticleOncotarget2016

Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells.

Elyse K Hanly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.